Description: Negative control for PP 2 (Cat. No. 1407)
Chemical Name: 1-Phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
Purity: ≥98% (HPLC)
Biological Activity
Technical Data
Solubility
Calculators
Datasheets
References
Biological Activity
Negative control for the Src kinase inhibitor PP 2 (Cat. No. 1407). Inhibits EGFR kinase (IC50 = 2.7 μM).
Technical Data
M. Wt
211.22
Formula
C11H9N5
Storage
Store at -20°C
Purity
≥98% (HPLC)
CAS Number
5334-30-5
PubChem ID
4879
InChI Key
KKDPIZPUTYIBFX-UHFFFAOYSA-N
Smiles
NC1=NC=NC2=C1C=NN2C3=CC=CC=C3
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Solubility Data
Solvent
Max Conc. mg/mL
Max Conc. mM
Solubility
DMSO
21.12
100
ethanol
5.28
25
Preparing Stock Solutions
The following data is based on the product molecular weight 211.22. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass
1 mg
5 mg
10 mg
1 mM
4.73 mL
23.67 mL
47.34 mL
5 mM
0.95 mL
4.73 mL
9.47 mL
10 mM
0.47 mL
2.37 mL
4.73 mL
50 mM
0.09 mL
0.47 mL
0.95 mL
Molarity Calculator
Molarity Calculator
Calculate the mass, volume, or concentration required for a solution.
Reconstitution Calculator
Reconstitution Calculator
Dilution Calculator
Dilution Calculator
Calculate the dilution required to prepare a stock solution.
Product Datasheets
Certificate of Analysis / Product Datasheet
Safety Datasheet
Select another language:
View SDS
References
References are publications that support the products' biological activity.
Traxleret al (1997) Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines. J.Med.Chem. 40 3601 PMID: 9357527
Houet al (2007) PP2, a potent inhibitor of Src family kinases, protects against hippocampal CA1 pyramidal cell death after transient global brain ischemia. Neurosci.Letts. 420 235 PMID: